The European Investment Bank (EIB), through its Group Chief Compliance Officer Gerhard Hütz, took part in the 10th conference of the Ethics Network of Multilateral Organisations (ENMO), which brings together the most senior professionals responsible for the Ethics functions in multilateral institutions. The event took place at the UN Ethics Office in New York from 10 to 13 July.
The EIB was recently admitted as a member of the ENMO. Members of the network, which includes the UN, EBRD and the World Bank, are committed to upholding the highest standards of professionalism, ethics, transparency and integrity.
The 10th ENMO Conference discussed a variety of ethics topics, exchanging on best practices and development of ethics programmes of participating organisations.
A speak-up culture
The conference was opened by UN Under-Secretary General Maria Luiza Ribeiro Viotti, Head of Cabinet, who delivered a message by the UN Secretary General promoting a strong Ethics programme and speak-up culture in international organisations. According to the message, the work of Ethics functions is “all the more crucial at a time when there is a crisis of public confidence in international organisations, national governments and aid agencies that rely on public funding in their efforts to help others around the world.”
Participants discussed conflicts of interest policies, whistleblowing policies, new policies against retaliation for reporting misconduct and for cooperating with investigations and audits, benchmarking and best practices of Ethics Offices, among others.
All subjects covered are of high importance for the EIB. The EU bank is currently revising its Codes of Conduct, Whistleblowing Policy and the Dignity at Work Policy.
How do we find a new development path that tackles inequality and empowers people so that people and the planet can prosper together? This is the question that UNDP Administrator Achim Steiner and EIB President Hoyer addressed today during a dialogue around the key findings of UNDP Human Development Report 2020.
Developing diagnostic and serological tests as well as vaccine strategies for preventing SARS-CoV-2 infection have been the areas that have benefited from an EIB Group donation to Institut Pasteur, in France.